At Amneal, we believe in reducing barriers to patients accessing the medicines they need most. In fact, Amneal’s founding 20-years ago was catalyzed by the desire to do something about the heartbreaking decision pharmacy patients were making between food and their essential medicines. That desire is amplified today with our broadening portfolio of quality products, including biosimilars – which we believe represent the future of accessibility to some of the most sophisticated therapies ever developed.
Constant innovation is the cornerstone of our business. Finding new ways to develop therapies more efficiently is fundamental to delivering safe, effective, high-quality products, all while improving affordability.